Abstract

Abstract: Antenatal Corticosteroids (ACS) are widely recommended in preterm deliveries as they promote lung maturation and reduce the risk of preterm neonatal morbidities and mortality. The purpose of this article is to review the evidence and provide evidence-based recommendations, the latest being FIGO 2021 and RCOG 2022 for the use of antenatal corticosteroids in management of women who are high risk of delivering preterm babies as a result of PPROM, Multiple gestation.